This talk will demonstrate how methylation biomarkers can be detected from liquid biopsy tests to support early cancer detection and monitoring.  

Using methylation based liquid biopsies as a tumour naive approach to detect MRD.  

Overcoming challenges and making these tests clincially viable,robust and scalable.